Amanda A Allshouse1, Sam MaWhinney, Catherine M Jankowski, Wendy M Kohrt, Thomas B Campbell, Kristine M Erlandson. 1. *Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Denver, Aurora, CO; †Division of Geriatric Medicine, Department of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO; ‡Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Colorado Denver, Aurora, CO; and §College of Nursing, Univeristy of Colorado Denver, Aurora, CO.
Abstract
OBJECTIVE: To determine the impact of self-reported marijuana use on the components of successful aging of HIV-infected persons. METHODS: Cross-sectional study of 45- to 65-year-old HIV-infected subjects on antiretroviral therapy >6 months with undetectable HIV-1 viral load. Successful aging was defined as absence of disease, adequate physical function, high quality of life (QOL), and social engagement. Clinical characteristics, physical function assessments, and QOL from short form 36 were compared between groups defined by self-reported recent marijuana use (RMU), adjusted for tobacco use, CD4 T-cell count, and time since HIV diagnosis, using logistic or linear regression for binary or continuous measures. RESULTS: 93 of 359 total subjects (26%) reported RMU. Demographically, patients reporting RMU had been diagnosed with HIV less recently [14 (13-16) vs 11 (10-12) years], reported smoking (48% vs 25%) and lower income (92% vs 80%) with greater prevalence than non-RMU patients; other demographics and clinical characteristics (age, CD4 T-cell count) were similar. Gender, race/ethnicity, physical outcomes, physical function, and disease burden were not significantly different. Patients reporting RMU demonstrated lower mental QOL and increased odds of low social engagement and un- or under-employment compared with nonusers. CONCLUSIONS: The negative association between RMU and mental or social QOL should be considered when assessing the success with which HIV patients reporting RMU are aging.
OBJECTIVE: To determine the impact of self-reported marijuana use on the components of successful aging of HIV-infectedpersons. METHODS: Cross-sectional study of 45- to 65-year-old HIV-infected subjects on antiretroviral therapy >6 months with undetectable HIV-1 viral load. Successful aging was defined as absence of disease, adequate physical function, high quality of life (QOL), and social engagement. Clinical characteristics, physical function assessments, and QOL from short form 36 were compared between groups defined by self-reported recent marijuana use (RMU), adjusted for tobacco use, CD4 T-cell count, and time since HIV diagnosis, using logistic or linear regression for binary or continuous measures. RESULTS: 93 of 359 total subjects (26%) reported RMU. Demographically, patients reporting RMU had been diagnosed with HIV less recently [14 (13-16) vs 11 (10-12) years], reported smoking (48% vs 25%) and lower income (92% vs 80%) with greater prevalence than non-RMUpatients; other demographics and clinical characteristics (age, CD4 T-cell count) were similar. Gender, race/ethnicity, physical outcomes, physical function, and disease burden were not significantly different. Patients reporting RMU demonstrated lower mental QOL and increased odds of low social engagement and un- or under-employment compared with nonusers. CONCLUSIONS: The negative association between RMU and mental or social QOL should be considered when assessing the success with which HIVpatients reporting RMU are aging.
Authors: Kevin P High; Mark Brennan-Ing; David B Clifford; Mardge H Cohen; Judith Currier; Steven G Deeks; Sherry Deren; Rita B Effros; Kelly Gebo; Jörg J Goronzy; Amy C Justice; Alan Landay; Jules Levin; Paolo G Miotti; Robert J Munk; Heidi Nass; Charles R Rinaldo; Michael G Shlipak; Russell Tracy; Victor Valcour; David E Vance; Jeremy D Walston; Paul Volberding Journal: J Acquir Immune Defic Syndr Date: 2012-07-01 Impact factor: 3.731
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: P K Nicholas; J G Voss; I B Corless; T G Lindgren; D J Wantland; J K Kemppainen; G E Canaval; E F Sefcik; K M Nokes; C A Bain; K M Kirksey; L S Eller; P J Dole; M J Hamilton; C L Coleman; W L Holzemer; N R Reynolds; C J Portillo; E H Bunch; Y-F Tsai; M R Mendez; S M Davis; D M Gallagher Journal: AIDS Care Date: 2007-11
Authors: Donald I Abrams; Joan F Hilton; Roslyn J Leiser; Starley B Shade; Tarek A Elbeik; Francesca T Aweeka; Neal L Benowitz; Barry M Bredt; Bradley Kosel; Judith A Aberg; Steven G Deeks; Thomas F Mitchell; Kathleen Mulligan; Peter Bacchetti; Joseph M McCune; Morris Schambelan Journal: Ann Intern Med Date: 2003-08-19 Impact factor: 25.391
Authors: Kristine M Erlandson; Amanda A Allshouse; Catherine M Jankowski; Syki Duong; Samantha Mawhinney; Wendy M Kohrt; Thomas B Campbell Journal: HIV Clin Trials Date: 2012 Nov-Dec
Authors: Chukwuemeka N Okafor; Robert L Cook; Xinguang Chen; Pamela J Surkan; James T Becker; Steve Shoptaw; Eileen Martin; Michael W Plankey Journal: Am J Drug Alcohol Abuse Date: 2016-11-03 Impact factor: 3.829
Authors: Aaron M Kipp; Peter F Rebeiro; Bryan E Shepherd; Lauren Brinkley-Rubinstein; Megan Turner; Sally Bebawy; Timothy R Sterling; Todd Hulgan Journal: AIDS Behav Date: 2017-07
Authors: Lisa Hightow-Weidman; Sara LeGrand; Seul Ki Choi; Joseph Egger; Christopher B Hurt; Kathryn E Muessig Journal: PLoS One Date: 2017-06-29 Impact factor: 3.240